Results 21 to 30 of about 8,262 (195)
Emergence and spread of O16-ST131 and O25b-ST131 clones among faecal CTX-M-producing Escherichia coli in healthy individuals in Hunan Province, China. [PDF]
OBJECTIVES The objectives of this study were to determine CTX-M-producing Escherichia coli ST131 strain prevalence in stool specimens from healthy subjects in central China and to molecularly characterize clonal groups.
Jian, Zi-Juan +5 more
core +3 more sources
Intestinal colonization traits of pandemic multidrug-resistant Escherichia coli ST131 [PDF]
Background. Epidemiological studies point to the gut as a key reservoir of multidrug resistant Escherichia coli multilocus sequence type 131 (ST131), a globally dominant pathogenic clone causing urinary tract and bloodstream infections.
Rinaldo Ruter +16 more
core +6 more sources
Comparison of Escherichia coli ST131 pulsotypes, by epidemiologic traits, 1967-2009 [PDF]
Escherichia coli sequence type 131 (ST131), an emerging disseminated public health threat, causes multidrug-resistant extraintestinal infections. Among 579 diverse E.
Mariana Castanheira +29 more
core +7 more sources
Emergence and spread of B2-ST131-O25b, B2-ST131-O16 and D-ST405 clonal groups among extended-spectrum-β-lactamase-producing Escherichia coli in Japan. [PDF]
[Objectives ]The increasing prevalence of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli has been associated with the emergence of the CTX-M-producing sequence type 131 (ST131) pandemic clonal group, a member of the O25b serogroup and ...
Ichiyama, Satoshi +7 more
core +5 more sources
Background Escherichia coli clinical sequence type 131 (ST131) has emerged as an extensively antimicrobial resistant E. coli clonal group in recent years throughout the world.
Bin Li +5 more
doaj +2 more sources
Background Escherichia coli serogroup O25b-sequence type 131 (E. coli O25-B2-ST131) is considered as multidrug-resistant and hypervirulent organism. There is lack of data about involvement of this pathogen in the children’s infection.
Razieh Shahbazi +5 more
doaj +3 more sources
Yi-Ming Zhong,1 Wen-En Liu,1 Qian Meng,2 Yuan Li21Department of Clinical Laboratory, Xiangya Hospital, Central South University, Changsha, People’s Republic of China; 2Faculty of Laboratory Medicine, Xiangya School of Medicine, Central South ...
Zhong YM, Liu WE, Meng Q, Li Y
doaj +4 more sources
Background: Commensal extended-spectrum β-lactamase (ESBL) producing Escherichia coli isolates in the gut can be the reservoir of virulence factors and resistance genes. Objectives: We investigated the molecular feature, risk factors, and quinolone/fluoroquinolone (Q/FQ) resistance in sequence type 131 (ST131) and non-ST131: ESBL-producing E. coli (EPE)
Azade Hajihasani +4 more
openaire +1 more source
Genotypic and Phenotypic Profiles of Escherichia coli Isolates Belonging to Clinical Sequence Type 131 (ST131), Clinical Non-ST131, and Fecal Non-ST131 Lineages from India [PDF]
ABSTRACT In view of the epidemiological success of CTX-M-15-producing lineages of Escherichia coli and particularly of sequence type 131 (ST131), it is of significant interest to explore its prevalence in countries such as India and to determine if antibiotic resistance, virulence, metabolic potential, and/
Arif, Hussain +5 more
openaire +2 more sources
The evolutionary puzzle of Escherichia coli ST131
The abrupt expansion of Escherichia coli sequence type (ST) 131 is unmatched among Gram negative bacteria. In many ways, ST131 can be considered a real-world model for the complexities involved in the evolution of a multidrug resistant pathogen. While much progress has been made on our insights into the organism's population structure, pathogenicity ...
Pitout, Johann D.D., Finn, Thomas J.
openaire +3 more sources

